Odunsi K - Search Results

1

Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers.

Zhu Q, Wang J, Yu H, Hu Q, Bateman NW, Long M, Rosario S, Schultz E, Dalgard CL, Wilkerson MD, Sukumar G, Huang RY, Kaur J, Lele SB, Zsiros E, Villella J, Lugade A, Moysich K, Conrads TP, Maxwell GL, Odunsi K. Zhu Q, et al. Among authors: odunsi k. Cancers (Basel). 2022 May 10;14(10):2350. doi: 10.3390/cancers14102350. Cancers (Basel). 2022. PMID: 35625955 Free PMC article.

2

The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.

Odunsi KO, Lele S, Ghamande S, Seago P, Driscoll DL. Odunsi KO, et al. Eur J Gynaecol Oncol. 2001;22(5):325-30. Eur J Gynaecol Oncol. 2001. PMID: 11766731

3

Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases.

Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S. Anupol N, et al. Among authors: odunsi k. Gynecol Oncol. 2002 Jun;85(3):487-92. doi: 10.1006/gyno.2002.6653. Gynecol Oncol. 2002. PMID: 12051879

4

Evaluation of beta1,4-galactosyltransferase as a potential biomarker for the detection of subclinical disease after the completion of primary therapy for ovarian cancer.

Odunsi K, Ghamande S, Chandrasekaran EV, Ta A, Moysich KB, Driscoll D, Matta K, Lele S. Odunsi K, et al. Am J Obstet Gynecol. 2002 Sep;187(3):575-80. doi: 10.1067/mob.2002.125888. Am J Obstet Gynecol. 2002. PMID: 12237630

5

Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer.

Ghamande S, Lele S, Marchetti D, Baker T, Odunsi K. Ghamande S, et al. Among authors: odunsi k. Int J Gynecol Cancer. 2003 Mar-Apr;13(2):142-7. doi: 10.1046/j.1525-1438.2003.13045.x. Int J Gynecol Cancer. 2003. PMID: 12657114 Clinical Trial.

6

Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.

Ghadersohi A, Odunsi K, Lele S, Collins Y, Greco WR, Winston J, Liang P, Sood AK. Ghadersohi A, et al. Among authors: odunsi k. Oncol Rep. 2004 Feb;11(2):453-8. Oncol Rep. 2004. PMID: 14719083

7

Primary primitive neuroectodermal tumor of the uterus: a report of two cases and review of the literature.

Odunsi K, Olatinwo M, Collins Y, Withiam-Leitch M, Lele S, Spiegel GW. Odunsi K, et al. Gynecol Oncol. 2004 Feb;92(2):689-96. doi: 10.1016/j.ygyno.2003.09.029. Gynecol Oncol. 2004. PMID: 14766268 Review.

8

Clinicopathologic outcomes of laser conization for high-grade cervical dysplasia.

dos Santos L, Odunsi K, Lele S. dos Santos L, et al. Among authors: odunsi k. Eur J Gynaecol Oncol. 2004;25(3):305-7. Eur J Gynaecol Oncol. 2004. PMID: 15171305

9

Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.

Olawaiye A, Caesar L, Walsh D, Lyman M, Yeh J, Rodabaugh K, Marchetti D, Lele S, Odunsi K. Olawaiye A, et al. Among authors: odunsi k. Gynecol Oncol. 2004 Sep;94(3):796-802. doi: 10.1016/j.ygyno.2004.06.031. Gynecol Oncol. 2004. PMID: 15350375

10

SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.

Tammela J, Jungbluth AA, Qian F, Santiago D, Scanlan MJ, Keitz B, Driscoll D, Rodabaugh K, Lele S, Old LJ, Odunsi K. Tammela J, et al. Among authors: odunsi k. Cancer Immun. 2004 Oct 18;4:10. Cancer Immun. 2004. PMID: 15487888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page